UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
CTOR holding history
Citius Oncology, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CTOR overviewAll 13F holders of CTORFull Q2 2026 holdings
- Shares (Q2 2026)
- 334,619
- Value
- $217.5K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 334,619 | $217.5K | <0.1% | +297,779+808.3% | Added | Holders |
| Q1 2026 | 36,840 | $22.8K | <0.1% | +15,376+71.6% | Added | Holders |
| Q4 2025 | 21,464 | $21.5K | <0.1% | +21,409+38,925.5% | Added | Holders |
| Q3 2025 | 55 | $112 | <0.1% | −15,368−99.6% | Reduced | Holders |
| Q2 2025 | 15,423 | $67.1K | <0.1% | −34,322−69.0% | Reduced | Holders |
| Q1 2025 | 49,745 | $46.3K | <0.1% | +24,940+100.5% | Added | Holders |
| Q4 2024 | 24,805 | $28.5K | <0.1% | +23,173+1,419.9% | Added | Holders |
| Q3 2024 | 1,632 | $2.27K | <0.1% | +1,632 | New | Holders |